We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Rare Disease R&D to Expand Under Orphan Drug Proposal
Rare Disease R&D to Expand Under Orphan Drug Proposal
February 24, 2006
The Bush administration would expand tax credits for firms that manufacture drugs targeting rare diseases, known as orphan drugs, under a proposal that aims to ramp up research into these illnesses.